Instil Bio director granted options for 6,500 shares
Instil Bio director R. Kent McGaughy Jr received a stock option grant covering 6,500 shares of common stock at an exercise price of $7.93 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Instil Bio director R. Kent McGaughy Jr received a stock option grant covering 6,500 shares of common stock at an exercise price of $7.93 per share. The option vests in 12 substantially equal monthly installments starting on July 11, 2026, with any unvested portion vesting in full at the next annual stockholder meeting or upon death, Disability, or a Change in Control, subject to continued service.
Insider Trade Summary
Grant/Award: 6,500 shares
Grant/Award
1 txn
Insider
McGaughy R Kent Jr
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 6,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 6,500 contracts (Direct)
Footnotes (1)
- F1. The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).
Key Figures
Option grant size: 6,500 shares
Exercise price: $7.93 per share
Post-grant derivative holdings: 6,500 options
+2 more
5 metrics
Option grant size
6,500 shares
Stock Option (Right to Buy) granted to director
Exercise price
$7.93 per share
Conversion or exercise price of stock option
Post-grant derivative holdings
6,500 options
Total derivative securities following transaction
Option expiration
June 10, 2036
Expiration date of stock option award
Vesting start date
July 11, 2026
Commencement of 12 monthly vesting installments
Key Terms
Stock Option (Right to Buy), Continuous Service, Equity Incentive Plan, Change in Control, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Continuous Service financial
"subject to the Reporting Person's Continuous Service as defined in the Plan"
Equity Incentive Plan financial
"defined in the company's 2021 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Change in Control financial
"vest in full in the event of the Reporting Person's death, Disability or upon a Change in Control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Disability financial
"vest in full in the event of the Reporting Person's death, Disability or upon a Change in Control"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Instil Bio (TIL) report in this Form 4?
Instil Bio reported a grant of stock options to director R. Kent McGaughy Jr for 6,500 shares of common stock at a $7.93 exercise price, vesting over time subject to his continued service with the company.
What is the exercise price of the Instil Bio (TIL) option granted to McGaughy?
The stock option has an exercise price of $7.93 per share. This means the director can buy Instil Bio common stock at $7.93 once the option vests and subject to continued service conditions.
When do the new Instil Bio (TIL) options start vesting for McGaughy?
The option begins vesting on July 11, 2026, in 12 substantially equal monthly installments. Vesting is conditioned on the director’s Continuous Service under Instil Bio’s 2021 Equity Incentive Plan through the respective vesting dates.
Under what circumstances do McGaughy’s Instil Bio (TIL) options fully vest early?
Any unvested portion will vest in full at the next annual stockholder meeting if he remains in Continuous Service and will also fully vest upon his death, Disability, or a Change in Control as defined in Instil Bio’s 2021 Equity Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
